File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: COVID-19 vaccines versus pediatric hospitalization

TitleCOVID-19 vaccines versus pediatric hospitalization
Authors
Rosa, Duque JSLeung, DYip, KMLee, DHLSo, HKWong, WHSLau, YL
Issue Date21-Feb-2023
PublisherCell Press
Citation
Cell Reports Medicine, 2023, v. 4, n. 2 How to Cite?
DOI: http://dx.doi.org/10.1016/j.xcrm.2023.100936
Abstract

Vaccine effectiveness of BNT162b2 and CoronaVac against COVID-19-associated hospitalization and moderate-to-severe disease due to SARS-CoV-2 Omicron BA.2 is studied from the 1.36 million doses administered to 766,601 of 953,400 children aged 3-11 years and adolescents aged 12-18 years in Hong Kong as of April 2022. These vaccines confer substantial protection.


Persistent Identifierhttp://hdl.handle.net/10722/348803
ISSN
2666-3791
2023 Impact Factor: 11.7
2023 SCImago Journal Rankings: 4.276

 

DC FieldValueLanguage
dc.contributor.authorRosa, Duque JS-
dc.contributor.authorLeung, D-
dc.contributor.authorYip, KM-
dc.contributor.authorLee, DHL-
dc.contributor.authorSo, HK-
dc.contributor.authorWong, WHS-
dc.contributor.authorLau, YL-
dc.date.accessioned2024-10-16T00:30:16Z-
dc.date.available2024-10-16T00:30:16Z-
dc.date.issued2023-02-21-
dc.identifier.citationCell Reports Medicine, 2023, v. 4, n. 2-
dc.identifier.issn2666-3791-
dc.identifier.urihttp://hdl.handle.net/10722/348803-
dc.description.abstract<p>Vaccine effectiveness of BNT162b2 and CoronaVac against COVID-19-associated hospitalization and moderate-to-severe disease due to SARS-CoV-2 Omicron BA.2 is studied from the 1.36 million doses administered to 766,601 of 953,400 children aged 3-11 years and adolescents aged 12-18 years in Hong Kong as of April 2022. These vaccines confer substantial protection.</p>-
dc.languageeng-
dc.publisherCell Press-
dc.relation.ispartofCell Reports Medicine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleCOVID-19 vaccines versus pediatric hospitalization-
dc.typeArticle-
dc.identifier.doi10.1016/j.xcrm.2023.100936-
dc.identifier.pmid36801010-
dc.identifier.scopuseid_2-s2.0-85148366576-
dc.identifier.volume4-
dc.identifier.issue2-
dc.identifier.eissn2666-3791-
dc.identifier.issnl2666-3791-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats